Member Info for FriedmanSowell

Volume plus price normally means something.

Huge volume and a drop is a worse portent than huge volume and a rise.

I should add that on the plus side, someone bought that amount of shares without moving the price all that much.

Someone has either finally had enough and sold off a huge number of shares, or someone has found something out and sold off a huge number of shares. Either way, it doesn’t seem positive.

Can’t remember seeing this much volume particularly when apparently nothing has happened. I also wouldn’t countenance selling at this price unless I was certain some terrible news was round the corner.

I’m not sure of your calculation there. A dual listing on NASDAQ wouldn’t require dilution but would provide the opportunity for fundraising if required through dilution. On the assumption that the value of shares goes up with a dual listing, any future dilution would be done at a higher value and would therefore mean a smaller dilution.

I can understand the viewpoint that says investors should be patient and there have been hopeful signs recently. The idea that SOH hasn’t made terrible errors with this business and misled us is not a viewpoint that deserves much of a hearing.

At best, I can hope that he has learnt from his mistakes but it’d be foolish to take him at his word given his record. Regardless of nitpicking over the exact terminology used, the impression he tried to give was clear.

“ FS - as letitrun implied, you seem determined to read a negative into literally everything this company says & does.”

I can’t deny that I viewed the RNS with pessimism as I have many other news releases recently. In my defence, I’d say my judgement of them has been reflected in the market which seems to place the same value as I do on SOH’s projections and deals. A judgement based on years of previous misses.

For balance though, I did say that my hope was that this would lead to a flurry of announcements and that together they might add up to something so I was trying to find a silver lining.

The market has spoken.

You can't go from an imminent launch to no launch and a changed product 2 years later and expect investors to buy in.

SOH's stock is even lower than our company's. He's just not trusted any more and when that happens, news like today is treated with suspicion

“ It also says whilst they’ve changed the process & enzyme the product is exactly the same but purer & yields higher (the main issue)”

This is self contradictory. It cannot be different and the same. That’s chemically impossible

I was writing mine while Aquae posted his better researched version.

The previous RNS now looks a bit dishonest

I hate to say it but this reads as a net negative to me. Not just because once bitten, twice shy has been taken to the nth degree where we've been bitten repeatedly such that the rabid dog wouldn't been out down, but because of what can be inferred.

It reads like we had made serious progress a few years to ago and just at the point of partners adopting it in their products, a serious flaw was found. That's we've had to go back and start the whole process again doesn't bode well for timescales in my view and it also raises the potential for lots of inflection points along the way where things could go wrong....as they did last time.

My overall view as of now is that we let the perfect be the enemy of the good. We could have had a decent business but sold everything and threw the kitchen sink at a blockbuster sugar replacement that may end up bankrupting us.

Yes, I am being a Debbie Downer and I would be surprised if investors are taken in by this. I don't see the impact on share price that the last reach RNS generated a few years ago

I don't know the group dynamics here, but those numbers don't make sense?

Was it a typo that suggest the amount in B drops dramatically and then rises again?

Also, can you provide a link to where you got that from please.

Yes, retention of old deals is extremely important and it’s a serious concern that we can’t retain customers.

I stand by what I said previously about this being a paltry amount as revenue. Without any indication of margins, it's also not very helpful in shining a light on the company's journey towards profitability.

That's the crux of the matter here. The company simply MUST become profitable. As we know, it has survived this far by selling holdings in other companies and when that well is dry, the only option will be dilution of shares here. That'll be the worse of both worlds.

One glimmer of hope that has struck me over the past few days since this RNS is the possibility that this is the start of a stream of deals being announced. It wouldn't be unheard of for SOH to get news out in this way. As we're coming towards the end of the year this would certainly be a good time for it. I think that's why I described this deal as paltry, because in isolation it is. If it is accompanied in the near future with lots of similar or some much bigger deals, that puts it in a whole new light.

What does more liquidity equate to on Aquis. Is it up from £100 per day to £105 per day.

Ok then, I'll be the negative voice. This is paltry and if it is the culmination of months of our company's endeavours then I ask again, just what are the people we employ doing with their time all day and how are they adding value.

Does anyone believe there is enough work for one full time person on the business side?

Needs to close above 72 IMO and on this volume with this momentum, there's no reason why it shouldn't

I don't think the Indian product is going anywhere. It's far too complex a programme for people who by definition lack discipline in their eating. It has no chance of competing at scale with weight loss drugs IMO.

The Feel Ful is a different beast altogether and really does have the possibility of being a game changer. Even that is met with frustration from me both in how long it took someone to have such a simple idea of using our ingredient in such a convenient product, and also at our management's sloth in disseminating it to wider markets.

I would genuinely love to know what the people who draw a salary from our company do all day. I struggle to imagine there's a full day's work for one person.

Not sure it's alleged. We recently had an RNS stating they had sold and all sale RNS' are retrospective so it would be little surprise to anyone I think if we had another soon.

Not sure of the exact figures but our holding on Skin has dropped from 50% to low single digits. I'd be curious to know if SOH's personal holding in Skin has followed the same trajectory

The board is as dead as the stock price and the company's sales phone lines.

Big volume today and another big drop. Is it on the way to Armageddon

I clicked this link. Thank you for posting it. It was very helpful.

My understanding of this technology is in line with the level of investment I have made (about 4% of my portfolio), so I appreciate things being written so clearly.